Centaurus Financial Inc. Acquires New Shares in Danaher Corporation $DHR

Centaurus Financial Inc. acquired a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 24,949 shares of the conglomerate’s stock, valued at approximately $4,752,000.

Several other large investors also recently bought and sold shares of the company. Sivia Capital Partners LLC raised its stake in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after buying an additional 119 shares during the last quarter. First Trust Advisors LP boosted its position in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC grew its stake in Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC grew its stake in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after acquiring an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC increased its holdings in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after acquiring an additional 325 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on DHR shares. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Evercore reissued an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research note on Monday, July 6th. Piper Sandler started coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Finally, Royal Bank Of Canada upped their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

Get Our Latest Stock Report on Danaher

Danaher Trading Up 0.2%

Shares of DHR stock opened at $215.74 on Friday. The company has a market capitalization of $151.67 billion, a price-to-earnings ratio of 38.32, a PEG ratio of 2.68 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $198.69 and a 200 day moving average price of $192.35. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period last year, the company earned $0.77 EPS. Research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.